Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 18 Breast Neoplasms 16 Lung Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Melanoma 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Recurrence 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lung Diseases 2 Glioma 2 Glioblastoma 2 Genetic Predisposition to Disease 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2

Interventions

lutetium Lu 177 dotatate 12 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 cabozantinib 5 Everolimus 5 pembrolizumab 4 Nivolumab 4 olaparib 3 lenvatinib 3 Cyclophosphamide 3 177Lu-octreotide, DOTA(0)-Tyr(3)- 3 lanreotide 2 gallium Ga 68 dotatate 2 fludarabine phosphate 2 fludarabine 2 avelumab 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Phantoms, Imaging 2 Octreotide 2 Lutetium-177 2 Ipilimumab 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 tivozanib 1 surufatinib 1 repotrectinib 1 peposertib 1 pazopanib 1 entrectinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Blood Specimen Collection × 90 days × Clear all

NCT06430021 2026-05-22

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡